Circulation

Vol. 152, Issue 13 Issue 13 2025
11
Articles

Articles in this Issue

Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study

Rémi Goupil, Louis-Charles Desbiens, Amel Merabtine et al. Sep 30, 2025 pp. 913-923 10.1161/circulationaha.124.073507

BACKGROUND: Primary aldosteronism (PA), an overt form of renin-independent aldosterone production, leads to a disproportionately high rate of major adverse cardiovascular events (M...

Subclinical Primary Aldosteronism: A Potential New Target in Cardiovascular Prevention?

Wanpen Vongpatanasin, Jesslin Abraham, John M. Giacona Sep 30, 2025 pp. 924-926 10.1161/circulationaha.125.076085

Response by Bhatia and Tsimikas to Letter Regarding Article, “Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis”

Harpreet S. Bhatia, Sotirios Tsimikas Sep 30, 2025 10.1161/circulationaha.125.075455

Letter by Sechi et al Regarding Article, “Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Medicated Cardiovascular Risk: A Participant-Level Meta-Analysis”

Leonardo A. Sechi, Luca Bulfone, Cristiana Catena Sep 30, 2025 10.1161/circulationaha.124.073053

Targeting Calcium Regulation for Heart Failure and Arrhythmia Therapeutics: A Critical Review

Gabriel Redel-Traub, Steven O. Marx, Andrew R. Marks Sep 30, 2025 pp. 957-970 10.1161/circulationaha.125.075150

Despite advances in pharmacologic and procedural therapies, heart failure (HF) and cardiac arrhythmias remain significant global health burdens, highlighting the urgent need for novel therapeutic stra...

Letter by White et al Regarding Article, “Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial”

R. James White, Dominick Roto, Daniel Lachant Sep 30, 2025 10.1161/circulationaha.124.073132

Sudden Cardiac Arrest and Death Secondary to Congenital Coronary Artery Abnormalities in Young Competitive Athletes

Bradley J. Petek, Timothy W. Churchill, Nathaniel Moulson et al. Sep 30, 2025 pp. 971-973 10.1161/circulationaha.125.074330

Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry

Michael W.A. Chu, Ophélie Brault Meslin, George A. Wells et al. Sep 30, 2025 pp. 927-938 10.1161/circulationaha.124.073674

BACKGROUND: Comprehensive knowledge of the clinical presentation, contemporary management, and outcomes on “all-comer” patients referred for mitral valve surgery (MVS) are critical to eval...

Response by Jaber et al to Letter Regarding Article, “Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial”

Wissam A. Jaber, Carin F. Gonsalves, Stefan Stortecky et al. Sep 30, 2025 10.1161/circulationaha.125.075457

An Aberrant Resurgence of Endogenous Retroviruses Prompts Myocarditis and Heart Failure

Junhao Xiong, Shasha Zhang, Zilong Geng et al. Sep 30, 2025 pp. 939-956 10.1161/circulationaha.125.074845

BACKGROUND: Endogenous retroviruses (ERVs) occupy >8% of the human genome. Aberrant resurgence of ERVs has been implicated recently in several critical pathologies. However, the possibl...

Percutaneous Solutions for Tricuspid Regurgitation: Current Approved Options and Identifying Ideal Candidates

Gloria Ayuba, Anish Bhatt, Anthony Bavry Sep 30, 2025 pp. 909-912 10.1161/circulationaha.125.074143

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page